login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

Mechanochemical ablation shows 96% closure rate at two years


Friday, 08 Jun 2012 14:29
Steve Elias
Steve Elias

At two years, mechanochemical ablation (MOCA) is as efficacious as current endothermal techniques without the need of tumescent anaesthesia and is more effective than reported results of foam sclerotherapy of the great saphenous vein. Steve Elias, who presented the first-in-man two-year results with the technique at the Vascular Annual Meeting (Washington DC, USA,7–9 June 2012), said that MOCA is another alternative modality for most incompetent great and small saphenous veins.


Elias, director, Division of Vascular Surgery Vein Programs, Columbia University and Medical Center, New York, USA, told delegates that the mechanochemical ablation catheter (ClariVein, Vascular Insights) utilises a liquid sclerosant (sodium tetradecyl sulfate or aethoxysclerol) and a mechanical rotating wire to accomplish occlusion of incompetent great or small saphenous vein. The procedure does not require tumescence and is performed with local anaesthesia at the access site only. It can be characterised as mechanically enhanced sclerotherapy performed in an office setting.


Thirty great saphenous veins in 29 patients underwent micropuncture access with local anaesthesia only in this first-in-man study. Through a 5F micropuncture sheath the MOCA catheter was passed to a position 2cm from the saphenofemoral junction. Catheter wire rotation was begun for 3 seconds at 3,500rpm. With the wire rotating, infusion of sclerosant (1.5% sodium tetradecyl sulfate) and catheter pullback (1.5mm/sec) was begun simultaneously. A total of 12cc of sclerosant was used for each great saphenous vein. The procedure does not require the instillation of tumescent aneasthesia.


At one year, 29 of 30 great saphenous veins were successfully treated. Primary closure rate 96%. At two years, 24 patients were examined. All 24 remain closed. No deep vein thrombosis, nerve or skin injury occurred. Average total procedure time was 14 minutes. Catheter treatment time was five minutes. The MOCA technique has been modified; lower volumes are now used based on diameter and length of vein treated. Catheter placement is closer to saphenofemoral junction (1cm).

Elias said that 6,000 cases have been treated with MOCA worldwide, with >90% occlusion rate. Quality of life was improved as with any successful endovenous ablation intervention. Deep vein thrombosis rate was below 1% and there was no nerve/skin injury. Elias also told delegates what we have learned about the technique: “Rotate first (spasm/vortex) then inject slow. Catheter on is catheter moving. It is a two-handed technique, one pulls and one injects.

The tendency is to pull too fast and to inject too slow.” About volume, he said, that it originally was 12cc (1.5% STD) for all. Now, he added, volume is based on diameter/length and tends to be less. On concentration, he said that stronger is better.


Elias summarised his presentation saying that MOCA works and is safe, with a learning curve of five to eight cases. It does not involve the use of tumescence anaesthesia and is another good option for ablation.




Add New Comment

Related Items


Most popular


ROADSTER trial studying new path to carotid revascularisation completes patient enrolment
Friday, 18 Jul 2014
The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally ... ROADSTER trial studying new path to carotid revascularisation completes patient enrolment

Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category
Thursday, 17 Jul 2014
Two-year data from a prospective, multicentre study suggest that endovascular therapy with stenting may be considered the preferred first-line treatment option for aortoiliac lesions, irrespectively ... Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category

DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients
Friday, 29 Aug 2014
The multicentre, 800-patient study also demonstrated that directional atherectomy was non-inferior for treating peripheral arterial disease in patients with diabetes compared with those without ... DEFINITIVE LE study results show directional atherectomy is safe and effective in claudication and critical limb ischaemia patients

Features


Eversion carotid endarterectomy: A technique that matters
Wednesday, 10 Sep 2014
Philip S K Paty, Albany, USA, says that eversion carotid endarterectomy is the preferred technique to treat carotid artery disease. Over the past two decades, his centre has performed over 11,000 of ... Eversion carotid endarterectomy: A technique that matters

SPECT can predict cardiovascular mortality in elective aneurysm repair patients
Wednesday, 12 Mar 2014
Kimihiro Komori and Yosuke Inoue analyse the results of a study that concluded that preoperative pharmacologic stress myocardial perfusion SPECT is not only safe, but is also a useful method to ... SPECT can predict cardiovascular mortality in elective aneurysm repair patients

Profiles


Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Andrew Holden
Tuesday, 11 Feb 2014
Andrew Holden has been involved in the investigation of several endovascular devices for the ... Andrew Holden

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions